HLN
Haleon Sp ADR (HLN)
NYSE
$8.99+$0.22 (+2.50%)
Price as of Jun 23, 2026 5:36 PM EDT
  • $38.7B
    Market Cap
  • -14.74%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
11.0B
-1.81%
11.2B
-0.61%
11.3B
+4.09%
10.9B
N/A
Cost of Revenue
4.0B
-10.41%
4.4B
-3.21%
4.6B
+6.40%
4.3B
N/A
Gross Profit
7.1B
+3.75%
6.8B
+1.14%
6.7B
+2.58%
6.6B
N/A
Sales and Marketing Expense
4.4B
-1.98%
4.5B
+0.88%
4.4B
-1.56%
4.5B
N/A
Research and Development Expense
-316.0M
+6.04%
-298.0M
-4.18%
-311.0M
-203.67%
300.0M
N/A
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Operating Expenses
4.4B
-1.98%
4.5B
+0.88%
4.4B
-1.56%
4.5B
N/A
Operating Profit
2.4B
+9.34%
2.2B
+10.52%
2.0B
+9.37%
1.8B
N/A
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
0
N/A
0
N/A
0
N/A
0
N/A
Total Nonoperating Income and Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Income before Taxes
1.7B
+13.90%
1.5B
+32.76%
1.1B
-0.71%
1.1B
N/A
Income Taxes
472.0M
+8.51%
435.0M
-15.86%
517.0M
+3.61%
499.0M
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
1.7B
+13.90%
1.5B
+32.76%
1.1B
-0.71%
1.1B
N/A
Net Income from Continuing Operations Applicable to Common
1.7B
+13.90%
1.5B
+32.76%
1.1B
-0.71%
1.1B
N/A
Basic EPS and Net Income
0.19
+17.72%
0.16
+38.60%
0.11
-0.87%
0.12
N/A
Diluted EPS and Net Income
0.19
+17.83%
0.16
+38.94%
0.11
-1.74%
0.12
N/A
Basic Weighted Average Shares
9.0B
-1.64%
9.1B
-1.09%
9.2B
-0.02%
9.2B
N/A
Diluted Weighted Average Shares
9.0B
-1.64%
9.1B
-1.09%
9.2B
-0.02%
9.2B
N/A
Balance Sheet
Cash and Cash Equivalents
1.3B
-41.16%
2.3B
+115.52%
1.0B
+52.63%
684.0M
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
1.3B
-41.16%
2.3B
+115.52%
1.0B
+52.63%
684.0M
N/A
Total Current Assets
4.5B
-20.43%
5.7B
+18.68%
4.8B
+18.70%
4.1B
N/A
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
1.9B
+3.43%
1.8B
+1.63%
1.8B
+1.31%
1.8B
N/A
Total Long-Term Assets
28.1B
-1.81%
28.6B
-2.19%
29.2B
-4.94%
30.8B
N/A
Total Assets
32.6B
-4.91%
34.3B
+0.76%
34.1B
-2.18%
34.8B
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
4.9B
-15.12%
5.8B
+25.26%
4.6B
+6.18%
4.4B
N/A
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
11.2B
-8.68%
12.3B
-3.21%
12.7B
-9.31%
14.0B
N/A
Total Liabilities
16.1B
-10.75%
18.1B
+4.42%
17.3B
-5.62%
18.4B
N/A
Retained Earnings
27.8B
+2.11%
27.3B
-0.74%
27.5B
+2.78%
26.7B
N/A
Total Stockholders Equity
16.5B
+1.60%
16.2B
-3.02%
16.7B
+1.65%
16.5B
N/A
Total Shares Outstanding
9.0B
-1.45%
9.1B
-1.63%
9.2B
N/A
N/A
N/A
Cash Flow
Cash from Operating Activities
2.6B
+14.47%
2.3B
+9.57%
2.1B
+1.79%
2.1B
N/A
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
-346.0M
-165.53%
528.0M
+494.03%
-134.0M
-98.47%
-8.8B
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
-3.1B
+104.49%
-1.5B
-1.98%
-1.6B
-122.69%
6.9B
N/A
Financials Ratio
Gross Margin
64.19%
+5.66%
60.75%
+1.76%
59.70%
N/A
N/A
N/A
Operating Margin
21.87%
+11.35%
19.64%
+11.20%
17.66%
N/A
N/A
N/A
Return on Assets
5.02%
+16.32%
4.31%
+33.73%
3.23%
N/A
N/A
N/A
Return on Equity
10.27%
+14.75%
8.95%
+33.70%
6.70%
N/A
N/A
N/A
Revenue Growth
-1.81%
+196.02%
-0.61%
-114.93%
4.09%
N/A
N/A
N/A
Current Ratio
0.92
-6.24%
0.98
-5.26%
1.04
N/A
N/A
N/A
Cash Ratio
0.27
-30.66%
0.39
+72.04%
0.23
N/A
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow